1. Home
  2. PESI vs EYPT Comparison

PESI vs EYPT Comparison

Compare PESI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$17.46

Market Cap

370.3M

Sector

Industrials

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$3.84

Market Cap

419.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
EYPT
Founded
1990
1987
Country
United States
United States
Employees
307
N/A
Industry
Environmental Services
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
370.3M
419.9M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
PESI
EYPT
Price
$17.46
$3.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$31.80
AVG Volume (30 Days)
267.6K
4.0M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
$7,539,000.00
Revenue This Year
$34.62
N/A
Revenue Next Year
$77.02
$3,115.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.58
$3.42
52 Week High
$21.32
$19.11

Technical Indicators

Market Signals
Indicator
PESI
EYPT
Relative Strength Index (RSI) 46.61 31.98
Support Level $14.18 $3.95
Resistance Level $19.02 $14.72
Average True Range (ATR) 0.76 0.32
MACD -0.17 0.22
Stochastic Oscillator 5.18 39.33

Price Performance

Historical Comparison
PESI
EYPT

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: